Paloma Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,242
Closed -$78.7K 92
2025
Q1
$78.7K Buy
+22,242
New +$78.7K 0.01% 105
2024
Q3
Sell
-57,954
Closed -$110K 852
2024
Q2
$110K Buy
+57,954
New +$110K ﹤0.01% 652